Entity List

Hesai Group (HSAI) Tanks After US Claims it is Linked to Beijing’s Military - Hagens Berman

Retrieved on: 
Thursday, February 22, 2024
Entity List, SAN, Person, News, IPO, Hagens Berman, United, Security (finance)

SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now.

Key Points: 
  • SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .
  • “We’re investigating whether Hesai may have misled investors about its potential ties to the PRC military,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

Hesai Group (HSAI) Tanks After US Claims it is Linked to Beijing’s Military - - Hagens Berman

Retrieved on: 
Friday, February 16, 2024
Entity List, SAN, Person, News, IPO, Hagens Berman, United, Security (finance)

SAN FRANCISCO, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .
  • “We’re investigating whether Hesai may have misled investors about its potential ties to the PRC military,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

Hesai Group (HSAI) Tanks After US Claims it is Linked to Beijing’s Military - - Hagens Berman

Retrieved on: 
Monday, February 12, 2024
Entity List, SAN, Person, News, IPO, Hagens Berman, United, Security (finance)

SAN FRANCISCO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .
  • “We’re investigating whether Hesai may have misled investors about its potential ties to the PRC military,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

Hesai Group (HSAI) Tanks After US Claims it is Linked to Beijing’s Military - - Hagens Berman

Retrieved on: 
Friday, February 9, 2024
SAN, News, United, Hagens Berman, Person, Entity List, IPO, Security (finance)

SAN FRANCISCO, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Hesai Group (NASDAQ: HSAI) investors who purchased shares pursuant to Hesai’s Feb. 2023 IPO or on the open market thereafter and suffered substantial losses to submit your losses now .
  • “We’re investigating whether Hesai may have misled investors about its potential ties to the PRC military,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Hesai Group and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now .
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

China Continues to Enhance AI Chip Self-Sufficiency, but High-End AI Chip Development Remains Constrained, Says TrendForce

Retrieved on: 
Monday, December 11, 2023
Telecommunications, Software, Other Manufacturing, Hardware, Artificial Intelligence, Technology, Semiconductor, Manufacturing, Cloud, Entity List, LLM Communications, Acquisition, Research, DRAM, GUC, Acceleration, Commerce, Flash memory, Ecosystem, ASIC, SMIC, TSMC, CPU, NVIDIA, A100, H100, AMD, HPC, Partnership, Table, Ali Baba, EDA, AI, Baidu, HiSilicon, Video game, Huawei

This year, Baidu ordered over a thousand Ascend 910B chips from Huawei to build approximately 200 AI servers.

Key Points: 
  • This year, Baidu ordered over a thousand Ascend 910B chips from Huawei to build approximately 200 AI servers.
  • TrendForce conjectures that the next-generation Ascend 910B chip is likely manufactured using SMIC’s N+2 process.
  • There remains considerable potential for China to improve and establish a complete AI ecosystem.
  • Chinese CSPs like Baidu and Alibaba are actively investing in autonomous AI chip development.

SEAGATE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Seagate Technology Holdings Plc and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 7, 2023
Class Action Lawsuit, Professional Services, Legal, Acceleration, P.C, BIS, U.S. Department of Defense Strategy for Operating in Cyberspace, Seagate Technology, Jordan Economic and Commerce Bureau, Software, Telephone, Policy, Jeanne Eagels, EAR, Person, Seagate, Name, HDD, District court, Nature, Court, United, Entity List, News, Commerce, U.S. Department of Commerce Office of Security, Cryptocurrency, Huawei

Investors have until September 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • Seagate is a leading global supplier of data storage products, including hard disk drives (“HDDs”).
  • Over the following three trading days, Seagate’s stock price continued to drift lower, falling an additional nearly 7%.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, and Rain and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 2, 2023
Acceleration, P.C, BIS, Shareholder, U.S. Department of Defense Strategy for Operating in Cyberspace, Face, Seagate Technology, Jordan Economic and Commerce Bureau, Software, Baxter International, RAIN, Baxter, Policy, Survival, MANTRA, EAR, Person, Seagate, Name, HDD, Nature, United, FDA, Entity List, News, NYSE, Commerce, U.S. Department of Commerce Office of Security, Cryptocurrency, Audit, Pharmaceutical industry, Huawei

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • Seagate Technology Holdings Plc (NASDAQ: STX)
    Seagate is a leading global supplier of data storage products, including hard disk drives (“HDDs”).
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • For more information on the Rain class action go to: https://bespc.com/cases/RAIN

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioXcel, Seagate, and Baxter and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 28, 2023
Acceleration, P.C, Institutional review board, BIS, Shareholder, Office of Inspector General, U.S. Department of Health and Human Services, Face, Seagate Technology, Jordan Economic and Commerce Bureau, Software, Baxter International, Baxter, Policy, Record, EAR, Person, Seagate, Nursing, Name, Food and Drug Administration Amendments Act of 2007, Dementia, HDD, Patient, Nature, Defendant, United, FDA, Therapy, Entity List, News, NYSE, Agitation, Food, Safety, Commerce, U.S. Department of Commerce Office of Security, Pharmaceutical industry, Cryptocurrency, Audit, Huawei

On December 15, 2021, the Company announced that it had initiated a program to evaluate BXCL501 for the treatment of acute agitation associated with Alzheimer’s disease.

Key Points: 
  • On December 15, 2021, the Company announced that it had initiated a program to evaluate BXCL501 for the treatment of acute agitation associated with Alzheimer’s disease.
  • The Company announced that the program consisted of two randomized, double-blind, placebo-controlled studies: TRANQUILITY II and TRANQUILITY III.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • For more information on the Baxter class action go to: https://bespc.com/cases/BAX

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ImmunityBio, BioXcel, and Seagate and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, August 22, 2023
GMP, Institutional review board, Good manufacturing practice, CMOS, Seagate, Patient, BLA, News, Commerce, Software, U.S. Department of Commerce Office of Security, P.C, Policy, Infection, EAR, Name, Food and Drug Administration, Dementia, FDA, Entity List, Safety, Vaccine, Biologics license application, BIS, Shareholder, Office of Inspector General, U.S. Department of Health and Human Services, Record, Immunotherapy, HDD, Immune system, Defendant, United, Therapy, Agitation, Jordan Economic and Commerce Bureau, Acceleration, Seagate Technology, Person, Nursing, Nature, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Cryptocurrency, Audit, Huawei, ImmunityBio COVID-19 vaccine

The Company offers immunotherapy and cell therapy platforms, including, inter alia, antibody cytokine fusion protein N-803, commercially referred to as “Anktiva”.

Key Points: 
  • The Company offers immunotherapy and cell therapy platforms, including, inter alia, antibody cytokine fusion protein N-803, commercially referred to as “Anktiva”.
  • The Company uses third-party contract manufacturing organizations (“CMOs”) to produce certain of its product candidates, including Anktiva.
  • In May 2022, ImmunityBio submitted a Biologics License Application (“BLA”) for Anktiva to the U.S. Food and Drug Administration (“FDA”).
  • For more information on the Seagate class action go to: https://bespc.com/cases/STX

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ImmunityBio, BioXcel, and Seagate and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 17, 2023
GMP, Institutional review board, Good manufacturing practice, CMOS, Seagate, Patient, BLA, News, Commerce, Software, U.S. Department of Commerce Office of Security, P.C, Policy, Infection, EAR, Name, Food and Drug Administration, Dementia, FDA, Entity List, Safety, Vaccine, Biologics license application, BIS, Shareholder, Office of Inspector General, U.S. Department of Health and Human Services, Record, Immunotherapy, HDD, Immune system, Defendant, United, Therapy, Agitation, Jordan Economic and Commerce Bureau, Acceleration, Seagate Technology, Person, Nursing, Nature, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Cryptocurrency, Audit, Huawei, ImmunityBio COVID-19 vaccine

The Company offers immunotherapy and cell therapy platforms, including, inter alia, antibody cytokine fusion protein N-803, commercially referred to as “Anktiva”.

Key Points: 
  • The Company offers immunotherapy and cell therapy platforms, including, inter alia, antibody cytokine fusion protein N-803, commercially referred to as “Anktiva”.
  • The Company uses third-party contract manufacturing organizations (“CMOs”) to produce certain of its product candidates, including Anktiva.
  • In May 2022, ImmunityBio submitted a Biologics License Application (“BLA”) for Anktiva to the U.S. Food and Drug Administration (“FDA”).
  • For more information on the Seagate class action go to: https://bespc.com/cases/STX